Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
filingDate |
2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2010151874-A |
titleOfInvention |
NEW MEDICINAL FORM FOR THE TREATMENT OF FUNGAL INFECTION |
abstract |
1. A new dosage form for the treatment of fungal infections, consisting of cholesterol-containing amphotericin B in suspension. ! 2. The dosage form according to claim 1, in which the ratio of lipid to amphotericin B varies from 45: 1 to 45:15. ! 3. The dosage form according to claim 1, in which the suspension used is a saline solution. ! 4. The dosage form according to claim 1, in which Amphotericin B is subjected to destruction by ultrasound to convert particles into smaller and less lamellar nanosomes with a diameter in the range of 20-200 nm. |
priorityDate |
2009-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |